Cargando…

Developing evidence-based recommendations for optimal interpregnancy intervals in high-income countries: protocol for an international cohort study

INTRODUCTION: Short interpregnancy interval (IPI) has been linked to adverse pregnancy outcomes. WHO recommends waiting at least 2 years after a live birth and 6 months after miscarriage or induced termination before conception of another pregnancy. The evidence underpinning these recommendations la...

Descripción completa

Detalles Bibliográficos
Autores principales: Marinovich, M Luke, Regan, Annette K, Gissler, Mika, Magnus, Maria C, Håberg, Siri Eldevik, Padula, Amy M, Mayo, Jonathan A, Shaw, Gary M, Ball, Stephen, Malacova, Eva, Gebremedhin, Amanuel T, Nassar, Natasha, Marston, Cicely, de Klerk, Nick, Betran, Ana Pilar, Pereira, Gavin F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352763/
https://www.ncbi.nlm.nih.gov/pubmed/30700492
http://dx.doi.org/10.1136/bmjopen-2018-027941
_version_ 1783390910238687232
author Marinovich, M Luke
Regan, Annette K
Gissler, Mika
Magnus, Maria C
Håberg, Siri Eldevik
Padula, Amy M
Mayo, Jonathan A
Shaw, Gary M
Ball, Stephen
Malacova, Eva
Gebremedhin, Amanuel T
Nassar, Natasha
Marston, Cicely
de Klerk, Nick
Betran, Ana Pilar
Pereira, Gavin F
author_facet Marinovich, M Luke
Regan, Annette K
Gissler, Mika
Magnus, Maria C
Håberg, Siri Eldevik
Padula, Amy M
Mayo, Jonathan A
Shaw, Gary M
Ball, Stephen
Malacova, Eva
Gebremedhin, Amanuel T
Nassar, Natasha
Marston, Cicely
de Klerk, Nick
Betran, Ana Pilar
Pereira, Gavin F
author_sort Marinovich, M Luke
collection PubMed
description INTRODUCTION: Short interpregnancy interval (IPI) has been linked to adverse pregnancy outcomes. WHO recommends waiting at least 2 years after a live birth and 6 months after miscarriage or induced termination before conception of another pregnancy. The evidence underpinning these recommendations largely relies on data from low/middle-income countries. Furthermore, recent epidemiological investigations have suggested that these studies may overestimate the effects of IPI due to residual confounding. Future investigations of IPI effects in high-income countries drawing from large, population-based data sources are needed to inform IPI recommendations. We aim to assess the impact of IPIs on maternal and child health outcomes in high-income countries. METHODS AND ANALYSIS: This international longitudinal retrospective cohort study will include more than 18 million pregnancies, making it the largest study to investigate IPI in high-income countries. Population-based data from Australia, Finland, Norway and USA will be used. Birth records in each country will be used to identify consecutive pregnancies. Exact dates of birth and clinical best estimates of gestational length will be used to estimate IPI. Administrative birth and health data sources with >99% coverage in each country will be used to identify maternal sociodemographics, pregnancy complications, details of labour and delivery, birth and child health information. We will use matched and unmatched regression models to investigate the impact of IPI on maternal and infant outcomes, and conduct meta-analysis to pool results across countries. ETHICS AND DISSEMINATION: Ethics boards at participating sites approved this research (approval was not required in Finland). Findings will be published in peer-reviewed journals and presented at international conferences, and will inform recommendations for optimal IPI in high-income countries. Findings will provide important information for women and families planning future pregnancies and for clinicians providing prenatal care and giving guidance on family planning.
format Online
Article
Text
id pubmed-6352763
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-63527632019-02-21 Developing evidence-based recommendations for optimal interpregnancy intervals in high-income countries: protocol for an international cohort study Marinovich, M Luke Regan, Annette K Gissler, Mika Magnus, Maria C Håberg, Siri Eldevik Padula, Amy M Mayo, Jonathan A Shaw, Gary M Ball, Stephen Malacova, Eva Gebremedhin, Amanuel T Nassar, Natasha Marston, Cicely de Klerk, Nick Betran, Ana Pilar Pereira, Gavin F BMJ Open Obstetrics and Gynaecology INTRODUCTION: Short interpregnancy interval (IPI) has been linked to adverse pregnancy outcomes. WHO recommends waiting at least 2 years after a live birth and 6 months after miscarriage or induced termination before conception of another pregnancy. The evidence underpinning these recommendations largely relies on data from low/middle-income countries. Furthermore, recent epidemiological investigations have suggested that these studies may overestimate the effects of IPI due to residual confounding. Future investigations of IPI effects in high-income countries drawing from large, population-based data sources are needed to inform IPI recommendations. We aim to assess the impact of IPIs on maternal and child health outcomes in high-income countries. METHODS AND ANALYSIS: This international longitudinal retrospective cohort study will include more than 18 million pregnancies, making it the largest study to investigate IPI in high-income countries. Population-based data from Australia, Finland, Norway and USA will be used. Birth records in each country will be used to identify consecutive pregnancies. Exact dates of birth and clinical best estimates of gestational length will be used to estimate IPI. Administrative birth and health data sources with >99% coverage in each country will be used to identify maternal sociodemographics, pregnancy complications, details of labour and delivery, birth and child health information. We will use matched and unmatched regression models to investigate the impact of IPI on maternal and infant outcomes, and conduct meta-analysis to pool results across countries. ETHICS AND DISSEMINATION: Ethics boards at participating sites approved this research (approval was not required in Finland). Findings will be published in peer-reviewed journals and presented at international conferences, and will inform recommendations for optimal IPI in high-income countries. Findings will provide important information for women and families planning future pregnancies and for clinicians providing prenatal care and giving guidance on family planning. BMJ Publishing Group 2019-01-29 /pmc/articles/PMC6352763/ /pubmed/30700492 http://dx.doi.org/10.1136/bmjopen-2018-027941 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Obstetrics and Gynaecology
Marinovich, M Luke
Regan, Annette K
Gissler, Mika
Magnus, Maria C
Håberg, Siri Eldevik
Padula, Amy M
Mayo, Jonathan A
Shaw, Gary M
Ball, Stephen
Malacova, Eva
Gebremedhin, Amanuel T
Nassar, Natasha
Marston, Cicely
de Klerk, Nick
Betran, Ana Pilar
Pereira, Gavin F
Developing evidence-based recommendations for optimal interpregnancy intervals in high-income countries: protocol for an international cohort study
title Developing evidence-based recommendations for optimal interpregnancy intervals in high-income countries: protocol for an international cohort study
title_full Developing evidence-based recommendations for optimal interpregnancy intervals in high-income countries: protocol for an international cohort study
title_fullStr Developing evidence-based recommendations for optimal interpregnancy intervals in high-income countries: protocol for an international cohort study
title_full_unstemmed Developing evidence-based recommendations for optimal interpregnancy intervals in high-income countries: protocol for an international cohort study
title_short Developing evidence-based recommendations for optimal interpregnancy intervals in high-income countries: protocol for an international cohort study
title_sort developing evidence-based recommendations for optimal interpregnancy intervals in high-income countries: protocol for an international cohort study
topic Obstetrics and Gynaecology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352763/
https://www.ncbi.nlm.nih.gov/pubmed/30700492
http://dx.doi.org/10.1136/bmjopen-2018-027941
work_keys_str_mv AT marinovichmluke developingevidencebasedrecommendationsforoptimalinterpregnancyintervalsinhighincomecountriesprotocolforaninternationalcohortstudy
AT reganannettek developingevidencebasedrecommendationsforoptimalinterpregnancyintervalsinhighincomecountriesprotocolforaninternationalcohortstudy
AT gisslermika developingevidencebasedrecommendationsforoptimalinterpregnancyintervalsinhighincomecountriesprotocolforaninternationalcohortstudy
AT magnusmariac developingevidencebasedrecommendationsforoptimalinterpregnancyintervalsinhighincomecountriesprotocolforaninternationalcohortstudy
AT habergsirieldevik developingevidencebasedrecommendationsforoptimalinterpregnancyintervalsinhighincomecountriesprotocolforaninternationalcohortstudy
AT padulaamym developingevidencebasedrecommendationsforoptimalinterpregnancyintervalsinhighincomecountriesprotocolforaninternationalcohortstudy
AT mayojonathana developingevidencebasedrecommendationsforoptimalinterpregnancyintervalsinhighincomecountriesprotocolforaninternationalcohortstudy
AT shawgarym developingevidencebasedrecommendationsforoptimalinterpregnancyintervalsinhighincomecountriesprotocolforaninternationalcohortstudy
AT ballstephen developingevidencebasedrecommendationsforoptimalinterpregnancyintervalsinhighincomecountriesprotocolforaninternationalcohortstudy
AT malacovaeva developingevidencebasedrecommendationsforoptimalinterpregnancyintervalsinhighincomecountriesprotocolforaninternationalcohortstudy
AT gebremedhinamanuelt developingevidencebasedrecommendationsforoptimalinterpregnancyintervalsinhighincomecountriesprotocolforaninternationalcohortstudy
AT nassarnatasha developingevidencebasedrecommendationsforoptimalinterpregnancyintervalsinhighincomecountriesprotocolforaninternationalcohortstudy
AT marstoncicely developingevidencebasedrecommendationsforoptimalinterpregnancyintervalsinhighincomecountriesprotocolforaninternationalcohortstudy
AT deklerknick developingevidencebasedrecommendationsforoptimalinterpregnancyintervalsinhighincomecountriesprotocolforaninternationalcohortstudy
AT betrananapilar developingevidencebasedrecommendationsforoptimalinterpregnancyintervalsinhighincomecountriesprotocolforaninternationalcohortstudy
AT pereiragavinf developingevidencebasedrecommendationsforoptimalinterpregnancyintervalsinhighincomecountriesprotocolforaninternationalcohortstudy